E617 20
Generic Name: oxymorphone
Pill imprint E617 20 has been identified as Opana ER 20 mg.
Opana ER is used in the treatment of pain and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy.
Opana ER 20 mg has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence.
See also related documents.
Opana ER Images
- Generic Name:
- oxymorphone
- Imprint:
-
E617 20
- Strength:
- 20 mg
- Color:
- Green
- Shape:
- Eight-sided
- Availability:
- Prescription only
- Inactive Ingredients:
- hypromellose
ferric oxide black
methylparaben
propylene glycol
silicified microcrystalline cellulose
sodium stearyl fumarate
TIMERx-N
titanium dioxide
triacetin
polysorbate 80
FD&C Blue No. 1
FD&C Yellow No. 6
D&C Yellow No. 10
- Drug Class:
- Narcotic analgesics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 2 - High potential for abuse
- Manufacturer:
- Endo Pharmaceuticals Inc.
- National Drug Code (NDC):
- 63481-0617
Advertisement
More Opana ER resources
- Opana ER Extended-Release Tablets (Wolters Kluwer)
- Opana ER (Cerner Multum)
- Opana ER (Micromedex) - Includes Dosage Information
- Opana ER (FDA)
Search Again
